Form D · Pharmaceuticals
Signature Pharmaceutical Solutions, LLC
The Woodlands, TX · CIK 0001581730
Offering snapshot reported Jul 26, 2013 · SEC filing
- Reported sold
- $200K Offering amount: $200K
- Investors reported
- 40 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jul 12, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 26, 2013 | Initial | $200,000 | No comparison | 40 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-200328
Source: Form D, filed Jul 26, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Laubenstein | Director, Executive |
| Richard Mc Millan | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8505 Technology Forest Place, Suite 803
The Woodlands, TX, 77381
The Woodlands, TX, 77381